Cargando…
P.0669 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19–related trauma
Autores principales: | Lombardozzi, G., Matrone, M., Amici, E., Trovini, G., Perrini, F., Giovanni, A. Di, Giovanetti, V., Kotzalidis, G.D., De Filippis, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716253/ http://dx.doi.org/10.1016/j.euroneuro.2021.10.631 |
Ejemplares similares
-
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma
por: De Filippis, Sergio, et al.
Publicado: (2022) -
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder
por: Kotzalidis, Georgios D., et al.
Publicado: (2021) -
A comprehensive evaluation of adverse childhood experiences, social–emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice
por: Trovini, Giada, et al.
Publicado: (2023) -
Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020) -
1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis
por: Borriello, Francesco, et al.
Publicado: (2023)